BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,408,804 | +62.1% | 16,880,000 | +31.1% | 0.00% | 0.0% |
| Q2 2023 | $10,121,267 | +18.3% | 12,880,000 | +11.7% | 0.00% | – |
| Q1 2023 | $8,554,851 | -31.3% | 11,530,000 | -57.4% | 0.00% | – |
| Q4 2022 | $12,458,274 | +55.8% | 27,060,000 | +100.0% | 0.00% | -100.0% |
| Q3 2022 | $7,997,000 | +25.1% | 13,530,000 | +17.3% | 0.00% | – |
| Q2 2022 | $6,390,000 | -15.0% | 11,530,000 | -8.7% | 0.00% | – |
| Q1 2022 | $7,519,000 | -37.3% | 12,630,000 | -22.1% | 0.00% | -100.0% |
| Q4 2021 | $11,985,000 | -47.8% | 16,205,000 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $22,954,000 | -5.8% | 16,605,000 | +12.2% | 0.00% | 0.0% |
| Q2 2021 | $24,375,000 | +28.6% | 14,805,000 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $18,948,000 | – | 11,480,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |